Dr. Cooney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-8500
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1998 - 2001
Case Western Reserve University School of MedicineClass of 1998
Certifications & Licensure
OH State Medical License 2000 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors Start of enrollment: 2005 Jun 01
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2006 Sep 26
- Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy Start of enrollment: 2006 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 409 citationsPhase II Study of Sorafenib in Patients With Metastatic or Recurrent SarcomasRobert G. Maki, David R. D'Adamo, Mary L. Keohan, Michael Saulle, Scott M. Schuetze
Journal of Clinical Oncology. 2009-07-01 - 604 citationsChemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED TrialChristos Kyriakopoulos, Yu-Hui Chen, Michael A. Carducci, Glenn Liu, David F. Jarrard
Journal of Clinical Oncology. 2018-01-31 - 1819 citationsChemohormonal Therapy in Metastatic Hormone-Sensitive Prostate CancerChristopher Sweeney, Yu-Hui Chen, Michael A. Carducci, Glenn Liu, David F. Jarrard
The New England Journal of Medicine. 2015-08-19
Press Mentions
Chutes & Ladders—Doubling down on R&D, Daiichi Makes Changes to U.S. Research UnitMarch 1st, 2019
PAREXEL Expands Oncology Expertise Through FDA and Medical Oncologist AppointmentsFebruary 27th, 2019
Sermonix Pharmaceuticals Announces Article Comparing ‘Traditional’ to ‘Just-in-Time’ Trial Enrollment Models Is Published in JCO Clinical Cancer InformaticsJune 27th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
